Related Content
Search Google Scholar for:
|
|
Science 8 January 1982: Vol. 215. no. 4529, pp. 127 - 134 DOI: 10.1126/science.7053564
|
|
Articles
Science, Vol 215, Issue 4529, 127-134
Copyright © 1982 by American Association for the Advancement of Science
Regional differences in the growth of normal and neoplastic cells
R Auerbach
and
W Auerbach
This article provides a review of the literature on anteroposterior differences in the growth and functional expression of normal and neoplastic cells. Diverse studies in immunology, wound healing, carcinogenesis, transplantation biology, and developmental biology are brought together to emphasize the practical implications of regional differences for research protocols in all these areas of research. The more fundamental question of mechanisms is approached by consideration of variations in the vascular supply, pattern of nervous system development, expression of temperature differentials, and the establishment of metabolic gradients during development.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome.
- J. F. Eary, F. O'Sullivan, J. O'Sullivan, and E. U. Conrad (2008)
J. Nucl. Med.
49, 1973-1979
| Abstract »
| Full Text »
| PDF »
- smedinx-11 is a planarian stem cell gap junction gene required for regeneration and homeostasis.
- N. J. Oviedo and M. Levin (2007)
Development
134, 3121-3131
| Abstract »
| Full Text »
| PDF »
- Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models.
- L. Varticovski, M. G. Hollingshead, A. I. Robles, X. Wu, J. Cherry, D. J. Munroe, L. Lukes, M. R. Anver, J. P. Carter, S. D. Borgel, et al. (2007)
Clin. Cancer Res.
13, 2168-2177
| Abstract »
| Full Text »
| PDF »
- Heterogeneity of Angiogenic Activity in a Human Liposarcoma: a Proposed Mechanism for "No Take" of Human Tumors in Mice.
- E.-G. Achilles, A. Fernandez, E. N. Allred, O. Kisker, T. Udagawa, W.-D. Beecken, E. Flynn, and J. Folkman (2001)
J Natl Cancer Inst
93, 1075-1081
| Abstract »
| Full Text »
| PDF »
- Differential Expression of Fibromodulin, a Transforming Growth Factor-{beta} Modulator, in Fetal Skin Development and Scarless Repair.
- C. Soo, F.-Y. Hu, X. Zhang, Y. Wang, S. R. Beanes, H. P. Lorenz, M. H. Hedrick, R. J. Mackool, A. Plaas, S.-J. Kim, et al. (2000)
Am. J. Pathol.
157, 423-433
| Abstract »
| Full Text »
| PDF »
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice.
- G. Bergers, K. Javaherian, K. Lo, J. Folkman, and D. Hanahan (1999)
Science
284, 808-812
| Abstract »
| Full Text »
- Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring.
- M Shah, D. Foreman, and M. Ferguson (1995)
J. Cell Sci.
108, 985-1002
| Abstract »
| PDF »
- Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents.
- M Shah, D. Foreman, and M. Ferguson (1994)
J. Cell Sci.
107, 1137-1157
| Abstract »
| PDF »
- Thin Malignant Melanomas and Recurrence Potential.
- H. M. Shaw, W. H. McCarthy, S. W. McCarthy, and G. W. Milton (1987)
Arch Surg
122, 1147-1150
| Abstract »
| PDF »
- Cerebral Lateralization: Biological Mechanisms, Associations, and Pathology: II. A Hypothesis and a Program for Research.
- N. Geschwind and A. M. Galaburda (1985)
Arch Neurol
42, 521-552
| Abstract »
| PDF »
- Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.
- J Folkman, R Langer, R. Linhardt, C Haudenschild, and S Taylor (1983)
Science
221, 719-725
| Abstract »
| PDF »
|
|